You are here:


Lybridos is designed specifically for the treatment of women who suffer from HSDD as a result of inhibitory mechanisms in the brain resulting from negative associations with sex.

Lybridos enhances sexual motivation, as does Lybrido, but adds an active agent to counter inhibitory mechanisms in the prefrontal cortex areas. Furthermore, Lybridos is hypothesized to be a potential treatment of SSRI-induced FSD.